Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 46Recruiting 18Terminated 8Not yet recruiting 5Unknown 4Active not recruiting 3Withdrawn 2No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 289Lymphoma 45Recurrence 29Neoplasms, Plasma Cell 28Hematologic Neoplasms 25Smoldering Multiple Myeloma 20Lymphoma, Non-Hodgkin 19Neoplasms 13Leukemia, Lymphocytic, Chronic, B-Cell 11Myelodysplastic Syndromes 10Leukemia 10Immunoglobulin Light-chain Amyloidosis 10Leukemia, Myeloid, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Lymphoma, Mantle-Cell 6Prostatic Neoplasms 5Paraproteinemias 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Breast Neoplasms 5Lymphoproliferative Disorders 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Diseases 4Colorectal Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Monoclonal Gammopathy of Undetermined Significance × Plasma cell × Clear all
NCT04850846 2026-02-09

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
60 enrolled 10 charts
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT04920084 2025-09-09

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
23 enrolled 9 charts
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT05831358 2025-08-17

Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

Case Comprehensive Cancer Center

Phase NA Active not recruiting
201 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡